Stockreport

JPM26: Regeneron will not overpay in M&A deals amid lead asset patent expiries [Yahoo! Finance]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF its internal R&D capacity to develop next-generation assets and expand into new indications. Speaking at the J.P. Morgan Healthcare conference in San Francisco, held f [Read more]